- Home
- NXPL vs CLDI Comparison
NXPL vs CLDI Comparison
Compare NXPL & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPL
- CLDI
- Stock Information
- Founded
- NXPL 1997
- CLDI 2014
- Country
- NXPL United States
- CLDI United States
- Employees
- NXPL N/A
- CLDI N/A
- Industry
- NXPL Telecommunications Equipment
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXPL Telecommunications
- CLDI Health Care
- Exchange
- NXPL Nasdaq
- CLDI Nasdaq
- Market Cap
- NXPL 17.9M
- CLDI 20.2M
- IPO Year
- NXPL N/A
- CLDI N/A
- Fundamental
- Price
- NXPL $0.71
- CLDI $1.57
- Analyst Decision
- NXPL
- CLDI
- Analyst Count
- NXPL 0
- CLDI 0
- Target Price
- NXPL N/A
- CLDI N/A
- AVG Volume (30 Days)
- NXPL 59.9K
- CLDI 476.7K
- Earning Date
- NXPL 08-14-2025
- CLDI 08-08-2025
- Dividend Yield
- NXPL N/A
- CLDI N/A
- EPS Growth
- NXPL N/A
- CLDI N/A
- EPS
- NXPL N/A
- CLDI N/A
- Revenue
- NXPL $58,766,000.00
- CLDI N/A
- Revenue This Year
- NXPL N/A
- CLDI N/A
- Revenue Next Year
- NXPL N/A
- CLDI N/A
- P/E Ratio
- NXPL N/A
- CLDI N/A
- Revenue Growth
- NXPL N/A
- CLDI N/A
- 52 Week Low
- NXPL $0.43
- CLDI $1.51
- 52 Week High
- NXPL $2.30
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- NXPL 47.50
- CLDI 29.64
- Support Level
- NXPL $0.66
- CLDI $1.51
- Resistance Level
- NXPL $0.84
- CLDI $1.73
- Average True Range (ATR)
- NXPL 0.06
- CLDI 0.30
- MACD
- NXPL -0.00
- CLDI -0.03
- Stochastic Oscillator
- NXPL 27.11
- CLDI 1.66
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.